Effects of interleukin-12p40 gene transfer on rat corneal allograft survival

Transplant Immunology

Volumn 18, Issue 2, 2007, Pages 101-107

  Ritter, Thomas ^a   Yang, Jun ^a   Dannowski, Haike ^a   Vogt, Katrin ^a   Volk, Hans Dieter ^a   Pleyer, Uwe ^a  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

Author keywords

Adenovirus; Cornea transplantation; Gene therapy; IL 12p40; Immunomodulation

Indexed keywords

ADENOVIRUS VECTOR; GAMMA INTERFERON; INTERLEUKIN 12P40; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; MESSENGER RNA;

ALLOTRANSPLANTATION; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; CORNEA TRANSPLANTATION; DRUG EFFECT; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GRAFT REJECTION; GRAFT SURVIVAL; IMMUNOMODULATION; IMMUNOREGULATION; KERATOPLASTY; NONHUMAN; ORGAN DONOR; PRIORITY JOURNAL; RAT; T LYMPHOCYTE; VIRAL GENE DELIVERY SYSTEM; VIRAL GENE THERAPY;

ADENOVIRIDAE; ANIMALS; CORNEAL TRANSPLANTATION; CYTOKINES; FEMALE; GENE TRANSFER TECHNIQUES; GRAFT REJECTION; GRAFT SURVIVAL; INTERFERON TYPE II; INTERLEUKIN-12 SUBUNIT P40; RATS; RATS, INBRED LEW; RATS, INBRED WF; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER;

EID: 36048958245     PISSN: 09663274     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.trim.2007.05.004     Document Type: Article

References (31)

1. Pleyer U., Dannowski H., Volk H.D., and Ritter T. Corneal allograft rejection: current understanding. I. Immunobiology and basic mechanisms. Ophthalmologica 215 (2001) 254-262
2. George A.J., and Larkin D.F. Corneal transplantation: the forgotten graft. Am J Transplant 4 (2004) 678-685
3. Coster D.J., and Williams K.A. The impact of corneal allograft rejection on the long-term outcome of corneal transplantation. Am J Ophthalmol 140 (2005) 1112-1122
4. Gately M.K., Desai B.B., Wolitzky A.G., Quinn P.M., Dwyer C.M., Podlaski F.J., et al. Regulation of human lymphocyte proliferation by a heterodimeric cytokine, IL-12 (cytotoxic lymphocyte maturation factor). J Immunol 147 (1991) 874-882
5. King W.J., Comer R.M., Hudde T., Larkin D.F., and George A.J. Cytokine and chemokine expression kinetics after corneal transplantation. Transplantation 70 (2000) 1225-1233
6. Liu Y., Dana M.R., Tewari V., and Taylor A.W. Immune response to intragraft antigen in draining lymph nodes after corneal transplantation is mediated by interleukin-12. J Interferon Cytokine Res 21 (2001) 813-819
7. Gillessen S., Carvajal D., Ling P., Podlaski F.J., Stremlo D.L., Familletti P.C., et al. Mouse interleukin-12 (IL-12) p40 homodimer: a potent IL-12 antagonist. Eur J Immunol 25 (1995) 200-206
8. Kato K., Shimozato O., Hoshi K., Wakimoto H., Hamada H., Yagita H., et al. Local production of the p40 subunit of interleukin 12 suppresses T-helper 1-mediated immune responses and prevents allogeneic myoblast rejection. Proc Natl Acad Sci U S A 93 (1996) 9085-9089
9. Yasuda H., Nagata M., Arisawa K., Yoshida R., Fujihira K., Okamoto N., et al. Local expression of immunoregulatory IL-12p40 gene prolonged syngeneic islet graft survival in diabetic NOD mice. J Clin Invest 102 (1998) 1807-1814
10. Pleyer U., and Ritter T. Gene therapy in immune-mediated diseases of the eye. Prog Retin Eye Res 22 (2003) 277-293
11. Jun A.S., and Larkin D.F. Prospects for gene therapy in corneal disease. Eye 17 (2003) 906-911
12. Williams K.A., Jessup C.F., and Coster D.J. Gene therapy approaches to prolonging corneal allograft survival. Expert Opin Biol Ther 4 (2004) 1059-1071
13. Mohan R.R., Sharma A., Netto M.V., Sinha S., and Wilson S.E. Gene therapy in the cornea. Prog Retin Eye Res 24 (2005) 537-559
14. Larkin D.F., Oral H.B., Ring C.J., Lemoine N.R., and George A.J. Adenovirus-mediated gene delivery to the corneal endothelium. Transplantation 61 (1996) 363-370
15. Ritter T., Vogt K., Rieck P., Schilling-Schon A., Kolls J., Hartmann C., et al. Adenovirus-mediated gene transfer of interleukin-4 to corneal endothelial cells and organ cultured corneas leads to high IL-4 expression. Exp Eye Res 69 (1999) 563-568
16. Klebe S., Coster D.J., Sykes P.J., Swinburne S., Hallsworth P., Scheerlinck J.P., et al. Prolongation of sheep corneal allograft survival by transfer of the gene encoding ovine IL-12-p40 but not IL-4 to donor corneal endothelium. J Immunol 175 (2005) 2219-2226
17. Fallaux F.J., Kranenburg O., Cramer S.J., Houweling A., Van Ormondt H., Hoeben R.C., et al. Characterization of 911: a new helper cell line for the titration and propagation of early region 1-deleted adenoviral vectors. Hum Gene Ther 7 (1996) 215-222
18. Kolls J., Peppel K., Silva M., and Beutler B. Prolonged and effective blockade of tumor necrosis factor activity through adenovirus-mediated gene transfer. Proc Natl Acad Sci U S A 91 (1994) 215-219
19. Aboalchamat B., Engelmann K., Bohnke M., Eggli P., and Bednarz J. Morphological and functional analysis of immortalized human corneal endothelial cells after transplantation. Exp Eye Res 69 (1999) 547-553
20. Gong N., Pleyer U., Yang J., Vogt K., Hill M., Anegon I., et al. Influence of local and systemic CTLA4Ig gene transfer on corneal allograft survival. J Gene Med 8 (2006) 459-467
21. Gong N., Pleyer U., Volk H.D., and Ritter T. Effects of local and systemic viral interleukin-10 gene transfer on corneal allograft survival. Gene Ther 14 (2007) 484-490
22. Ardjomand N., McAlister J.C., Rogers N.J., Tan P.H., George A.J., and Larkin D.F. Modulation of costimulation by CD28 and CD154 alters the kinetics and cellular characteristics of corneal allograft rejection. Invest Ophthalmol Vis Sci 44 (2003) 3899-3905
23. Hamrah P., Liu Y., Zhang Q., and Dana M.R. The corneal stroma is endowed with a significant number of resident dendritic cells. Invest Ophthalmol Vis Sci 44 (2003) 581-589
24. Klebe S., Sykes P.J., Coster D.J., Krishnan R., and Williams K.A. Prolongation of sheep corneal allograft survival by ex vivo transfer of the gene encoding interleukin-10. Transplantation 71 (2001) 1214-1220
25. Moore K.W., de Waal Malefyt R., Coffman R.L., and O'Garra A. Interleukin-10 and the interleukin-10 receptor. Annu Rev Immunol 19 (2001) 683-765
26. Asadullah K., Sterry W., and Volk H.D. Interleukin-10 therapy-review of a new approach. Pharmacol Rev 55 (2003) 241-269
27. Torres P.F., De Vos A.F., van der Gaag R., Martins B., and Kijlstra A. Cytokine mRNA expression during experimental corneal allograft rejection. Exp Eye Res 63 (1996) 453-461
28. Huard J., Lochmuller H., Acsadi G., Jani A., Massie B., and Karpati G. The route of administration is a major determinant of the transduction efficiency of rat tissues by adenoviral recombinants. Gene Ther 2 (1995) 107-115
29. Kay M.A., Graham F., Leland F., and Woo S.L. Therapeutic serum concentrations of human alpha-1-antitrypsin after adenoviral-mediated gene transfer into mouse hepatocytes. Hepatology 21 (1995) 815-819
30. Qin L., Ding Y., Pahud D.R., Chang E., Imperiale M.J., and Bromberg J.S. Promoter attenuation in gene therapy: interferon-gamma and tumor necrosis factor-alpha inhibit transgene expression. Hum Gene Ther 8 (1997) 2019-2029
31. Ritter T., Brandt C., Prosch S., Vergopoulos A., Vogt K., Kolls J., et al. Stimulatory and inhibitory action of cytokines on the regulation of hCMV-IE promoter activity in human endothelial cells. Cytokine 12 (2000) 1163-1170